Literature DB >> 18053015

Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update.

J L Brozek1, C E Baena-Cagnani, S Bonini, G W Canonica, G Rasi, R G van Wijk, T Zuberbier, G Guyatt, J Bousquet, H J Schünemann.   

Abstract

BACKGROUND: We describe the methodology for the 2008 update of the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines. The methodology differs from the 2001 edition in several respects. The most prominent change is the application of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to compiling evidence, assessing the quality of evidence and grading of recommendations. METHODS AND
RESULTS: Representatives of the GRADE working group joined the ARIA guideline panel to achieve these tasks. While most recommendations result from existing systematic reviews, systematic reviews were not always available and the panel compiled the best available evidence in evidence profiles without conducting actual reviews. The panel conducted two meetings and used the GRADE criteria to assess the quality of evidence (four categories of high, moderate, low and very low) and the strength of recommendation (strong and weak) based on weighing up the desirable and undesirable effects of management strategies, considering values and preferences influencing recommendations, and resource implications. The guideline panel has chosen the words 'we recommend'--for strong recommendations and 'we suggest'--for weak recommendations. Both categories indicate the best course of action for a given patient population, but their implementation, requires different considerations as we describe subsequently in this article.
CONCLUSIONS: The 2008 update of the ARIA guidelines has become more evidence-based. Future iterations of the guidelines will further be improved by following the described processes even closer, such as ensuring availability of updated high quality systematic reviews for each question.

Entities:  

Mesh:

Year:  2008        PMID: 18053015     DOI: 10.1111/j.1398-9995.2007.01560.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  21 in total

1.  Comparative analysis of cluster versus conventional immunotherapy in patients with allergic rhinitis.

Authors:  Qijun Fan; Xuejun Liu; Jinjian Gao; Saiyu Huang; Liyan Ni
Journal:  Exp Ther Med       Date:  2017-01-05       Impact factor: 2.447

2.  Sub-lingual immunotherapy: world allergy organization position paper 2009.

Authors:  G Walter Canonica; Jean Bousquet; Thomas Casale; Richard F Lockey; Carlos E Baena-Cagnani; Ruby Pawankar; Paul C Potter; Philippe J Bousquet; Linda S Cox; Stephen R Durham; Harold S Nelson; Giovanni Passalacqua; Dermot P Ryan; Jan L Brozek; Enrico Compalati; Ronald Dahl; Luis Delgado; Roy Gerth van Wijk; Richard G Gower; Dennis K Ledford; Nelson Rosario Filho; Erkka J Valovirta; Osman M Yusuf; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2009-11-19       Impact factor: 4.084

3.  Lack of bone metabolism side effects after 3 years of nasal topical steroids in children with allergic rhinitis.

Authors:  Ozkaya Emin; Mete Fatih; Dibek Emre; Samanci Nedim
Journal:  J Bone Miner Metab       Date:  2011-02-17       Impact factor: 2.626

Review 4.  Comparative analysis of allergic rhinitis in children and adults.

Authors:  Adriana Izquierdo-Domínguez; Antonio L Valero; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

5.  Allergy: a risk factor for suicide?

Authors:  Teodor T Postolache; Hirsh Komarow; Leonardo H Tonelli
Journal:  Curr Treat Options Neurol       Date:  2008-09       Impact factor: 3.598

6.  [GA2LEN (Global Allergy and Asthma European Network), the perspective of the German speaking centers].

Authors:  Stefan Wöhrl; Katja Radon; Johannes Ring; Katharina Moritz; Cezmi Akdis; Peter Burney; Paul Van Cauwenberge; Jean Bousquet; Torsten Zuberbier
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

7.  World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines.

Authors:  Alessandro Fiocchi; Jan Brozek; Holger Schünemann; Sami L Bahna; Andrea von Berg; Kirsten Beyer; Martin Bozzola; Julia Bradsher; Enrico Compalati; Motohiro Ebisawa; Maria Antonieta Guzman; Haiqi Li; Ralf G Heine; Paul Keith; Gideon Lack; Massimo Landi; Alberto Martelli; Fabienne Rancé; Hugh Sampson; Airton Stein; Luigi Terracciano; Stefan Vieths
Journal:  World Allergy Organ J       Date:  2010-04-23       Impact factor: 4.084

8.  [Allergic rhinitis and its impact on asthma (ARIA update 2008). The Austrian perspective].

Authors:  Isabella Pali-Schöll; Wolfgang Pohl; Werner Aberer; Felix Wantke; Friedrich Horak; Erika Jensen-Jarolim; Nikolai Khaltaev; Jean Bousquet
Journal:  Wien Med Wochenschr       Date:  2009

9.  Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper.

Authors:  Giovanni Passalacqua; Enrico Compalati; Giorgio Walter Canonica
Journal:  World Allergy Organ J       Date:  2010-07       Impact factor: 4.084

10.  Allergic Rhinitis and Its Impact on Asthma in Asia Pacific and the ARIA Update 2008.

Authors:  Ruby Pawankar; Chaweewan Bunnag; Nikolai Khaltaev; Jean Bousquet
Journal:  World Allergy Organ J       Date:  2012-04-17       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.